BrightSpring Health Services Files S-1 for Potential IPO

TL;DR

<b>BrightSpring Health Services has filed an S-1, signaling its intent to go public.</b>

AI Summary

BrightSpring Health Services, Inc. (BTSGU) filed a IPO Registration (S-1) with the SEC on January 2, 2024. BrightSpring Health Services, Inc. has filed an S-1 registration statement with the SEC. The filing indicates the company is preparing for a public offering of its securities. The company's principal executive offices are located at 805 N. Whittington Parkway, Louisville, KY 40222. The filing was made on January 2, 2024, under the Securities Act of 1933. BrightSpring Health Services operates within the Home Health Care Services industry (SIC code 8082).

Why It Matters

For investors and stakeholders tracking BrightSpring Health Services, Inc., this filing contains several important signals. This S-1 filing is a crucial step for BrightSpring Health Services as it seeks to raise capital and increase its public profile through an Initial Public Offering (IPO). The filing provides potential investors with detailed information about the company's business, financial condition, and risks, enabling them to make informed investment decisions.

Risk Assessment

Risk Level: medium — BrightSpring Health Services, Inc. shows moderate risk based on this filing. The company is a non-accelerated filer and an emerging growth company, suggesting it may be in an earlier stage of development or has not yet met the thresholds for accelerated filer status, which could imply less established financial reporting or operational scale compared to larger, more mature public companies.

Analyst Insight

Monitor future filings for updated financial performance and details regarding the IPO pricing and offering size.

Key Numbers

• 333-276348 — SEC File Number (Registration Statement)
• 82-2956404 — IRS Employer Identification No. (Company Tax ID)
• 1231 — Fiscal Year End (Company Financial Reporting)
• 8082 — SIC Code (Home Health Care Services)

Key Players & Entities

• BrightSpring Health Services, Inc. (company) — Registrant name
• 0001193125-24-000734 (filing_id) — Accession Number
• 20240102 (date) — Filing Date
• 805 N. Whittington Parkway, Louisville, Kentucky 40222 (address) — Registrant's principal executive offices
• Steven S. Reed (person) — Chief Legal Officer and Corporate Secretary
• Simpson Thacher & Bartlett LLP (company) — Legal counsel
• Latham & Watkins LLP (company) — Legal counsel
• 8082 (industry_code) — Standard Industrial Classification Code

Forward-Looking Statements

• BrightSpring Health Services, Inc. will complete its initial public offering (IPO) (BrightSpring Health Services, Inc.) — medium confidence, target: Q1 2024

FAQ

Risk Factors

• Regulatory Compliance [high — regulatory]: The company must comply with extensive federal, state, and local regulations governing healthcare services, which could lead to penalties or operational disruptions if not met.
• Dependence on Reimbursement [high — financial]: A significant portion of revenue is derived from government healthcare programs (Medicare, Medicaid) and managed care organizations, making the company vulnerable to changes in reimbursement rates or policies.
• Staffing and Labor Shortages [medium — operational]: The company relies on a large workforce of skilled caregivers, and shortages or increased labor costs could impact service delivery and profitability.
• Competition [medium — market]: The home health and community-based services market is competitive, with numerous providers potentially impacting market share and pricing power.

Key Dates

• 2024-01-02: S-1 Filing — Initiation of the public offering process.

Key Financial Figures

• $2,400 — dication adherence and an approximately $2,400 per member per year reduction in total
• $1.0 — its combined market opportunity of over $1.0 trillion by starting with the projected
• $944 billion — d Medicare and Medicaid expenditures of $944 billion and $805 billion, respectively, and sub
• $805 b — dicaid expenditures of $944 billion and $805 billion, respectively, and subtracting pr
• $623 billion — e and Medicaid hospital expenditures of $623 billion and adding projected total pharmacy exp
• $225 billion — and Medicaid pharmacy expenditures, of $225 billion. The Companys platform is purpose-built

Filing Documents

• d251968ds1.htm (S-1) — 3998KB
• d251968dex231.htm (EX-23.1) — 1KB
• d251968dex991.htm (EX-99.1) — 2KB
• d251968dexfilingfees.htm (EX-FILING FEES) — 49KB
• g251968g01g00.jpg (GRAPHIC) — 461KB
• g251968g02t98.jpg (GRAPHIC) — 134KB
• g251968g03g03.jpg (GRAPHIC) — 113KB
• g251968g14g14.jpg (GRAPHIC) — 99KB
• g251968g70c01.jpg (GRAPHIC) — 64KB
• g251968g70c02.jpg (GRAPHIC) — 71KB
• g251968g70c03.jpg (GRAPHIC) — 58KB
• g251968g70c04.jpg (GRAPHIC) — 80KB
• 0001193125-24-000734.txt (&nbsp;) — 5528KB

Forward-Looking Statements

Forward-Looking Statements 83

Use of Proceeds

Use of Proceeds 86 Dividend Policy 87 Capitalization 88

Managements Discussion and Analysis of Financial Condition and Results

Managements Discussion and Analysis of Financial Condition and Results of Operations 92

Business

Business 136 Management 176

Executive Compensation

Executive Compensation 183 Certain Relationships and Related Party Transactions 206 Principal Stockholders 210 Tangible Equity Units Offering 212

Description of Capital Stock

Description of Capital Stock 214 Description of Certain Indebtedness 222 Shares Eligible for Future Sale 226 Material U.S. Federal Income Tax Consequences to Non-U.S. Holders 228 Underwriting (Conflicts Of Interest) 231 Legal Matters 239 Experts 239 Where You Can Find More Information 239 Index to Financial Statements F-1 Through and including the 25th day after the date of this prospectus, all dealers that effect transactions in these shares of our common stock, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers obligations to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. You should rely only on the information contained in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. Neither we nor the underwriters have authorized anyone to provide you with different information. The information in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus, or any free writing prospectus, as the case may be, or any sale of shares of our common stock. For investors outside the United States: we are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions where offers and sales are permitted. Neither we nor the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus outside the United States. i Table of Contents INDUSTRY AND MARKET DATA Within this prospectus, w

View Full Filing

View this S-1 filing on SEC EDGAR